Who to call at Perspective Therapeutics, Inc., and when
Fundz watches for the moments Perspective Therapeutics, Inc. starts buying, and tells you who to reach.
- An alert the day Perspective Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Perspective Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Perspective Therapeutics, Inc.. With Fundz connected, it knows.
Perspective Therapeutics, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
perspectivetherapeutics.comAI Executive Summary
AI-powered analysis of 8-K filing content
Perspective Therapeutics amended and restated employment agreements with CEO Johan (Thijs) Spoor, Chief Accounting Officer Jonathan Hunt, and CMO Dr. Markus Puhlmann, setting base salaries at $680,000, $451,500, and $516,700 and revising change-in-control severance terms. The changes define the executives' post-transaction economics, which matters for investors assessing retention risk and deal costs.
Key Takeaways
Base salaries are set at $680,000 for CEO Spoor, $451,500 for CAO Hunt, and $516,700 for CMO Puhlmann, replacing the 2023 agreements.
Change-in-control severance applies if an executive is terminated without Cause or resigns for Good Reason from three months before to 12 months after a Change in Control, subject to a signed release.
3 more takeaways
Related Filings (24)
24 more filings from Perspective Therapeutics, Inc. in the last 90 days
Filing Overview
What This Means
Perspective Therapeutics, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.